Ellington Financial Inc. Other Income (Expense) decreased by 66.4% to $4.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 81.5%, from $24.27M to $4.48M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 30.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.17M | $1.42M | $13.73M | $1.22M | -$166.00K | -$31.00K | $4.36M | $3.50M | $5.69M | $28.77M | $2.99M | $7.51M | $7.65M | $1.58M | $11.85M | $24.27M | $12.30M | $2.56M | $13.31M | $4.48M |
| QoQ Change | — | -34.5% | +868.2% | -91.1% | -113.6% | +81.3% | >999% | -19.6% | +62.4% | +405.7% | -89.6% | +151.2% | +1.9% | -79.3% | +649.3% | +104.8% | -49.3% | -79.2% | +419.2% | -66.4% |
| YoY Change | — | — | — | — | -107.7% | -102.2% | -68.3% | +187.2% | >999% | >999% | -31.4% | +114.3% | +34.5% | -94.5% | +296.3% | +223.2% | +60.7% | +62.1% | +12.3% | -81.5% |